🇺🇸 FDA
Patent

US 10759774

Inhibitors of hepatitis B virus targeting capsid assembly

granted A61KA61K31/18A61K31/381

Quick answer

US patent 10759774 (Inhibitors of hepatitis B virus targeting capsid assembly) held by Regents of the University of Minnesota expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/18, A61K31/381, A61K31/4155, A61K31/427